Education
About Us
Working with TipRanks
Follow Us
Medico Remedies Ltd. (IN:MEDICO)
:MEDICO
MEDICO Stock Chart & Stats
₹50.16
₹4.58(8.10%)
At close: 4:00 PM EST
₹50.16
₹4.58(8.10%)
Day’s Range― - ―
52-Week Range₹35.00 - ₹67.47
Previous CloseN/A
Volume2.72M
Average Volume (3M)12.74K
Market Cap
₹3.88B
Enterprise Value₹3.93B
Total Cash (Recent Filing)₹25.45M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)32.9
Beta<0.01
Next Earnings
May 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.35
Shares Outstanding82,984,000
10 Day Avg. Volume20,955
30 Day Avg. Volume12,740
Financial Highlights & Ratios
PEG Ratio1.99
Price to Book (P/B)7.06
Price to Sales (P/S)2.92
P/FCF Ratio258.26
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue And Improving MarginsSustained double-digit revenue growth and improving net margins indicate the company is scaling sales while extracting more profit per rupee of revenue. Over 2-6 months, this supports durable cash generation, reinvestment capacity, and competitive positioning in specialty/generic drugs.
Prudent Leverage And Solid Equity BaseA conservative capital structure with favorable debt levels enhances financial resilience during industry cycles and provides flexibility to fund R&D, regulatory processes, or small acquisitions. This strengthens long-term solvency and lowers refinancing and default risk.
Positive Operating Cash ConversionStrong conversion of net income into operating cash flow shows underlying earnings quality and supports sustainable internal funding for working capital and selective capex. Over months, reliable cash generation underpins reinvestment and strategic optionality.
Bears Say
Capex Pressure On Free Cash FlowElevated capex that meaningfully reduces free cash flow can constrain the company’s ability to pay down debt, return capital, or fund expansion without external financing. If sustained, it weakens liquidity flexibility and raises funding needs over the medium term.
Volatility In EBIT MarginUnstable EBIT margins point to sensitivity in cost structure or pricing power, which can lead to earnings unpredictability. Over 2-6 months this increases forecast risk, complicates capital allocation decisions, and may pressure returns if volatility persists.
Moderate Reliance On LiabilitiesA material reliance on liabilities versus equity heightens exposure to interest-rate shifts and refinancing cycles. In adverse market conditions it could limit strategic moves or increase financing costs, reducing long-term financial flexibility and risk tolerance.
Medico Remedies Ltd. News
MEDICO FAQ
What was Medico Remedies Ltd.’s price range in the past 12 months?
Medico Remedies Ltd. lowest stock price was ₹35.00 and its highest was ₹67.47 in the past 12 months.
What is Medico Remedies Ltd.’s market cap?
Medico Remedies Ltd.’s market cap is ₹3.88B.
When is Medico Remedies Ltd.’s upcoming earnings report date?
Medico Remedies Ltd.’s upcoming earnings report date is May 30, 2026 which is in 96 days.
How were Medico Remedies Ltd.’s earnings last quarter?
Medico Remedies Ltd. released its earnings results on Feb 12, 2026. The company reported ₹0.346 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.346.
Is Medico Remedies Ltd. overvalued?
According to Wall Street analysts Medico Remedies Ltd.’s price is currently Overvalued.
Does Medico Remedies Ltd. pay dividends?
Medico Remedies Ltd. does not currently pay dividends.
What is Medico Remedies Ltd.’s EPS estimate?
Medico Remedies Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medico Remedies Ltd. have?
Medico Remedies Ltd. has 82,984,000 shares outstanding.
What happened to Medico Remedies Ltd.’s price movement after its last earnings report?
Medico Remedies Ltd. reported an EPS of ₹0.346 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.509%.
Which hedge fund is a major shareholder of Medico Remedies Ltd.?
Currently, no hedge funds are holding shares in IN:MEDICO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Medico Remedies Ltd.
Medico Remedies Limited manufactures and sells allopathic pharmaceutical preparations in India. The company offers antibiotics and anti-infective drugs; beta-lactams, and penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, and anti-epileptics and antipsychotics products; antimalarial medicines; dry syrups; ointments and creams; anti-diabetics products; and syrups. It also exports its products to Kazakhstan, Kyrgyzstan, Botswana, Jamaica, and Niger. Medico Remedies Limited was incorporated in 1994 and is based in Mumbai, India.
Technical Analysis
Albert David Ltd
―
Brooks Laboratories Limited
―
Lyka Labs Limited
―
―
Zim Laboratories Ltd.
―